Search clinical trials for: Bioresorbable Vascular Scaffold System

Total 266245 results

Biotyx Medical (Shenzhen) Co., Ltd.
VascuScience GmbH; Mediolanum Cardio Research Srl; Euroimage Research Srl

Recruiting

IBS Titan™ Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System Clinical Trial

Critical Limb Ischemia | Infrapopliteal Lesions

Italy
Meril Life Sciences Pvt. Ltd.

Not yet recruiting

Non-inferiority Clinical Trial to Compare the Safety and Performance of MeRes100 Sirolimus-eluting BioResorbable Vascular Scaffold System Versus Contemporary DES Platforms in Patients With de Novo Coronary Artery Lesions (MeRethonRCT)

Coronary Artery Disease
Biotyx Medical (Shenzhen) Co., Ltd.

Recruiting

A Clinical Trial to Evaluate the Safety and Efficacy of IBS Angel in Patients With Pulmonary Artery Stenosis (IRIS)

Pulmonary Artery Stenosis

China
Efemoral Medical, Inc.

Recruiting

The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery (Efemoral I)

Vascular Diseases | Peripheral Arterial Disease | Stenosis | Femoropopliteal Stenosis

New Zealand, Australia
Shanghai Bio-heart Biological Technology Co., Ltd.
CCRF Inc., Beijing, China

Not yet recruiting

A Registry Trial of The Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System

Coronary Artery Disease

China
Meril Life Sciences Pvt. Ltd.

Not yet recruiting

Study of MeRes100 in the Treatment of Patient With Coronary Artery Disease. (MeReS100-China)

Coronary Artery Disease
Samsung Medical Center

Terminated

P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold (SMART-CHOICEII)

Coronary Artery Disease | Atherosclerosis | Stents

Korea, Republic of
Abbott Medical Devices

Active, not recruiting

LIFE-BTK PK Sub-study

Critical Limb Ischemia (CLI)

Taiwan, United States, Australia
Seung-Jung Park
CardioVascular Research Foundation, Korea

Withdrawn

BVS Implantation in Patients With Variant Angina and MODerate Coronary Artery Disease (BIVA-pilot)

Angina Pectoris, Variant

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Active, not recruiting

Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events (BVS LATE)

Coronary Disease | Percutaneous Transluminal Coronary Angioplasty

Korea, Republic of
Abbott Medical Devices

Active, not recruiting

LIFE-BTK Randomized Controlled Trial (LIFE-BTK)

Critical Limb Ischemia (CLI)

United States, Hong Kong, Australia, New Zealand, Singapore, Taiwan
Pauls Stradins Clinical University Hospital

Active, not recruiting

Chronic Total Coronary Occlusion Treatment Results 6 Years After Bioresorbable Scaffold Implantation (CTO_BVS)

Coronary Artery Disease | Angina Pectoris | Occlusion, Coronary

Latvia
Abbott Medical Devices

Completed

ABSORB III Randomized Controlled Trial (RCT) (ABSORB-III)

Coronary Artery Disease | Coronary Disease | Coronary Stenosis | Coronary Artery Stenosis

United States, Australia
Odense University Hospital

Active, not recruiting

Optimal Predilatation Treatment Before Implantation of a Magmaris Bioresorbable Scaffold in Coronary Artery Stenosis (OPTIMIS)

Myocardial Infarction | Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Artery Disease | Coronary Disease | Arterial Occlusive Diseases | Stable Angina | Coronary Artery Stenosis | Atherosclerosis of Artery

Denmark
Elixir Medical Corporation

Completed

Elixir Medical Clinical Evaluation of the DESolve Myolimus Eluting Bioresorbable Coronary Stent System - DESolve I Trial

Coronary Artery Disease

New Zealand, Belgium
Elixir Medical Corporation

Completed

Elixir Medical Clinical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - The DESolve Nx Trial

Coronary Artery Disease

New Zealand, Belgium, Germany, Poland, Denmark, Brazil
Biotyx Medical (Shenzhen) Co., Ltd.

Active, not recruiting

A Clinical Investigation to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease (IRONMAN-II)

Coronary Artery Disease

China
Biotyx Medical (Shenzhen) Co., Ltd.

Active, not recruiting

A Clinical Trial to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease (IRONMAN-III)

Coronary Artery Disease

China
Papworth Hospital NHS Foundation Trust

Completed

Coronary Microcirculatory and Bioresorbable Vascular Scaffolds (EMPIRE-BVS)

Myocardial Ischemia | Angina, Stable | CHD - Coronary Heart Disease

United Kingdom
Elixir Medical Corporation

Completed

Elixir Medical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - Cx Registry

Coronary Artery Disease

Belgium, Brazil
Changi General Hospital

Completed

Drug Impregnated Bioabsorbable Stent in Asian Population Extremity Arterial Revascularization (DISAPEAR Study) (DISAPEAR)

Critical Limb Ischemia

Singapore
University of Ulm

Completed

Coronary and Structural Interventions Ulm - Bioresorbable Vascular Scaffold (CSI-Ulm-BVS)

Coronary Artery Disease | Ischemic Heart Disease | Stable Angina | Acute Myocardial Infarction | Unstable Angina

Germany
Abbott Medical Devices

Completed

A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System in Chinese Population ~ ABSORB CHINA Randomized Controlled Trial (RCT) (ABSORB CHINA)

Coronary Artery Disease | Coronary Disease | Coronary Stenosis | Coronary Artery Stenosis

United States
Shanghai Bio-heart Biological Technology Co., Ltd.
CCRF Inc., Beijing, China

Active, not recruiting

Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System Clinical Study

Coronary Artery Disease | Antineoplastic Agents

China
Abbott Medical Devices

Completed

ABSORB II Randomized Controlled Trial (ABSORB II)

Coronary Artery Disease

Belgium
University of Luebeck
Charite University, Berlin, Germany; Kerckhoff Klinik; University of Schleswig-Holstein...

Terminated

EverolimuS-ElUtinG BioresorbAble VasculaR Scaffolds vErsus EVerolimus-Eluting Stents in Patients With Diabetes Mellitus (SUGAR-EVE)

Coronary Artery Disease | Diabetes Mellitus

Germany
480 Biomedical

Completed

480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo Superficial Femoral Artery (SFA) Lesions (STANCE)

Atherosclerosis of Femoral Artery | Superficial Femoral Artery Lesions

New Zealand, Austria, Australia, Germany
Abbott Medical Devices

Completed

ESPRIT I: A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbable Vascular Scaffold) System

Atherosclerosis | Peripheral Vascular Disease | Claudication

Austria, France, Germany, Belgium
Abbott Medical Devices

Completed

To Study the Safety and Clinical Outcomes of the Absorb Bioresorbable Vascular Scaffold (BVS) System in Patients With de Novo Lesions in Previously Untreated Vessels (ABSORB UK)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

United Kingdom
International Foundation for Development of Medical...
KCRI

Completed

Feasibility and Outcomes of Complete Coronary Revascularization Using BVS in All-comer Patients With Angina (FEASTRU)

Angina

Russian Federation
Meril Life Sciences Pvt. Ltd.

Unknown

Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System (MeRes-1Extend)

Coronary Artery Disease

Malaysia, Brazil, Indonesia, Macedonia, The Former Yugoslav Republic of
Institut d'Investigació Biomèdica de Bellvitge
Fundació La Marató de TV3

Completed

Comparison of the Vasomotor Function and Myocardial Flow in Patients Treated With Bioresorbable and Metallic Stents at 1 Year (BVS-Flow)

Stable Angina

Spain
Luzerner Kantonsspital

Unknown

Absorb Bioresorbable Scaffold vs. Drug Coated Balloon for Treatment Of In-Stent-Restenosis

In-stent Restenosis
KCRI
SIS Medical AG

Completed

Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds (OPreNBiS)

Coronary Artery Disease | Angina, Stable | Angina, Unstable

Switzerland
Seung-Jung Park
CardioVascular Research Foundation, Korea

Terminated

Quantitative Coronary Angiography Versus Imaging GUIDancE for Bioresorbable Vascular Scaffold Implantation (GUIDE-BVS)

Percutaneous Transluminal Coronary Angioplasty

Korea, Republic of
SIS Medical AG

Unknown

Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds (OPreNBiS)

Coronary Artery Disease | Stable Angina | Unstable Angina | Angina

Switzerland
Ottawa Heart Institute Research Corporation

Withdrawn

Comparative Response to Vascular Injury in Patients With Diabetes Mellitus: An OCT Study of BVS Versus Xience DES

Coronary Artery Disease | Diabetes Mellitus
Lepu Medical Technology (Beijing) Co., Ltd.

Unknown

NeoVas Bioresorbable Coronary Scaffold Randomized Controlled Trial

Coronary Artery Disease

China
Aarhus University Hospital Skejby

Completed

DOCTOR Compare - A Study in the "DOCTOR" Series (Does Optical Coherence Tomography Optimize Revascularization?"

Myocardial Infarction | Coronary Disease | Atherosclerosis

Denmark
National Taiwan University Hospital

Unknown

Imaging and Interventional Study for Erectile Dysfunction and Lower Urinary Tract Symptoms (PERFECT)

Lower Urinary Tract Symptoms | Peripheral Arterial Disease | Erectile Dysfunction

Taiwan
Konstantinos Toutouzas
Université Catholique de Louvain; University of Patras; Centre Hospitalier Universitaire... and other collaborators

Not yet recruiting

3rd Generation Resorbable Magnesium Scaffolds vs Biodegradable Polymer Stents in NSTE/ACS

Coronary Artery Disease | Acute Coronary Syndrome

Belgium, Switzerland, Greece
ETS Wound Care, LLC
Professional Education and Research Institute

Recruiting

Bioresorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers (BGWM)

Diabetic Foot | Diabetic Foot Ulcer | Ulcer Foot

United States
Hokkaido University Hospital
Japan Agency for Medical Research and Development

Recruiting

Intracerebral Transplantation of Autologous MSC Combined With Scaffold Product for Chronic Intracerebral Hemorrhage (RAINBOW-Hx)

Intracerebral Hemorrhage

Japan
R3 Vascular Inc.

Recruiting

Evaluation of the MAGNITUDE® Bioresorbable Drug-Eluting Scaffold in the Treatment of Patients With Below the Knee Disease in Australia (MAGNITUDE-BTK)

Critical Limb Ischemia | Critical Lower Limb Ischemia | Critical Limb-Threatening Ischemia

Australia
R3 Vascular Inc.

Not yet recruiting

Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease (ELITE-BTK)

Chronic Limb-Threatening Ischemia
Biotronik AG
Biotronik AG

Not yet recruiting

Safety and Clinical Performance of the DREAMS 3G Resorbable Magnesium Scaffold System (BIOMAG-II)

Myocardial Ischemia | Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome | Ischemic Heart Disease | Atherosclerosis, Coronary
REVA Medical, Inc.

Recruiting

MOTIV BTK Randomized Controlled Trial

Critical Limb Ischemia

United States, Germany
R3 Vascular Inc.
Cardiovascular Research Foundation, New York; Massachusetts General Physicians...

Recruiting

Study of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease (RESOLV I)

Peripheral Arterial Disease | Lower Extremity Claudication | Lower Extremity Ischemia | Atherosclerotic Lesion

Canada, Italy, Austria
Biotyx Medical (Shenzhen) Co., Ltd.

Recruiting

IBS Titan vs. PTA in Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease (GENIUS)

Critical Limb Ischemia (CLI)

China
Biotronik AG

Recruiting

Resorbable Magnesium Scaffolds Registry

Coronary Artery Disease

Germany

Search clinical trials for: Bioresorbable Vascular Scaffold System

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations